Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123675742 | 12367574 | 2 | F | 20160414 | 20160602 | 20160513 | 20160705 | PER | US-JNJFOC-20160417068 | JANSSEN | 36.51 | YR | A | M | Y | 129.28000 | KG | 20160705 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123675742 | 12367574 | 1 | PS | INVEGA | PALIPERIDONE | 1 | Oral | Y | U | 16AG107 | 21999 | 9 | MG | OROS (ORAL OSMOTIC) THERAPEUTIC SYSTEM TABLET | BID | ||||
| 123675742 | 12367574 | 2 | SS | INVEGA SUSTENNA | PALIPERIDONE PALMITATE | 1 | Intramuscular | U | U | UNKNOWN | 0 | 234 | MG | INJECTION | |||||
| 123675742 | 12367574 | 3 | SS | INVEGA SUSTENNA | PALIPERIDONE PALMITATE | 1 | Intramuscular | U | U | UNKNOWN | 22264 | 234 | MG | INJECTION | |||||
| 123675742 | 12367574 | 4 | C | LITHIUM. | LITHIUM | 1 | Unknown | 0 | 1500 | MG | UNSPECIFIED | QD | |||||||
| 123675742 | 12367574 | 5 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Unknown | 0 | 1 | MG | UNSPECIFIED | BID | |||||||
| 123675742 | 12367574 | 6 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Unknown | 0 | 20 | MG | UNSPECIFIED | QD | |||||||
| 123675742 | 12367574 | 7 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 0 | 300 | MG | UNSPECIFIED | TID | |||||||
| 123675742 | 12367574 | 8 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 0 | 300 | MG | UNSPECIFIED | TID | |||||||
| 123675742 | 12367574 | 9 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 123675742 | 12367574 | 10 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Unknown | 0 | 10 | MG | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123675742 | 12367574 | 1 | Schizoaffective disorder |
| 123675742 | 12367574 | 2 | Schizoaffective disorder |
| 123675742 | 12367574 | 3 | Schizoaffective disorder |
| 123675742 | 12367574 | 4 | Psychotic disorder |
| 123675742 | 12367574 | 5 | Anxiety |
| 123675742 | 12367574 | 6 | Depression |
| 123675742 | 12367574 | 7 | Anxiety |
| 123675742 | 12367574 | 8 | Pain |
| 123675742 | 12367574 | 10 | Seasonal allergy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123675742 | 12367574 | Cognitive disorder | |
| 123675742 | 12367574 | Drug dose omission | |
| 123675742 | 12367574 | Insomnia | |
| 123675742 | 12367574 | Psychiatric decompensation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123675742 | 12367574 | 1 | 201503 | 0 | ||
| 123675742 | 12367574 | 2 | 20160415 | 0 | ||
| 123675742 | 12367574 | 4 | 2000 | 0 | ||
| 123675742 | 12367574 | 5 | 2000 | 0 | ||
| 123675742 | 12367574 | 6 | 201602 | 0 | ||
| 123675742 | 12367574 | 7 | 201401 | 0 | ||
| 123675742 | 12367574 | 8 | 201401 | 0 | ||
| 123675742 | 12367574 | 9 | 201401 | 0 |